Position in BCYC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$635,728
+$30,570 QoQ
Shares Held
149,936
+15.0% QoQ
Ownership
0.214%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 103 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BCYC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names. BCYC ranks #124 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in BCYC
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $635,728 | 149,936 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $605,158 | 130,422 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $543,595 | 76,779 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,335,166 | 430,900 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $12,319,570 | 1,772,600 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $31,345,665 | 3,692,069 | Shares | Defined | 2025-07-21 | |
| 2024-12-31 | $63,768,600 | 4,554,900 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $20,362,451 | 899,799 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,184,040 | 58,500 | Shares | Defined | 2024-09-16 | |
| 2024-03-31 | $8,530,590 | 342,594 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,084,181 | 225,895 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $26,106,955 | 1,299,500 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $12,198,560 | 478,000 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $17,067,048 | 802,400 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $29,836,148 | 1,007,978 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $29,201,022 | 1,255,418 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $24,247,100 | 1,445,000 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $71,076,911 | 1,619,802 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $95,737,736 | 1,572,823 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $67,171,676 | 1,615,092 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $54,828,186 | 1,805,935 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $47,119,715 | 1,577,493 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $25,804,489 | 1,437,576 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $25,968,026 | 1,363,151 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $6,303,854 | 400,499 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $5,466,811 | 400,499 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||